1 / 11

LRI/LOI Pilots

LRI/LOI Pilots. May 1 , 2012. Participants. Pilot I Project P articipants Allscripts Atlas Development CAP Cerner Halfpenny Technologies KHIE LabLynx RML. Coordination of Effort Validation Suite Vocabulary Group Implementation Guide Analysis Support Team Others.

james-blankenship
Download Presentation

LRI/LOI Pilots

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. LRI/LOI Pilots May 1, 2012

  2. Participants Pilot I Project Participants • Allscripts • Atlas Development • CAP • Cerner • Halfpenny Technologies • KHIE • LabLynx • RML Coordination of Effort • Validation Suite • Vocabulary Group • Implementation Guide Analysis • Support Team • Others Pilot II Project Participants Conversations • Lab System and EHR Vendor (2) • Lab System Vendor (1) • EHR Vendor (3) • Commercial Laboratories (2) • Provider Based Commercial Labs (3) Pilot I Project Participants • Allscripts • Cerner • Optimum Insight • RML

  3. LRI Validation Suite WGUpdate for LRI Pilot WG May 1, 2012

  4. Phase 1 Core Test Messages

  5. Phase 2 Test Messages* • Anatomical Pathology/Surgical Pathology Study • Example of A4 result • Two draft messages completed (Skin biopsy and Inguinal Lymph Node biopsy) • HIV 1 Ab [Presence] • Example of Reflex testing • Draft message completed • A toxicology test • Example of Screening followed by Reflex testing • Draft Screening message for Amphetamines [Presence] in Urine with negative result completed; Reflex draft message needed • Other test messages could include urine test for Cannabinoids, Cocaine, Opiates, Phencyclidine *Will start including in Validation Tool and Test Plans in June 2012

  6. Phase 2 Test Messages (cont’d) • Cytology Panel with four components • Example of combination of A2 and A4 results in a panel • Specimen source (identifier) in cervical or vaginal smear or scraping by Cyto stain – example of A2 result • Cytology report of cervical or vaginal smear or scraping Cyto stain thin prep – example of A4 result • Recommended follow-up (identifier) in cervical or vaginal smear or scraping by Cyto stain – example of A2 result • Cytology study comment on cervical or vaginal smear or scraping by Cyto stain – example of A4 result • Draft message needed

  7. Phase 2 Test Messages (cont’d) • Human Genome – CFTR gene mutations found [Identifier] • Example of A3 result • Draft message completed • Complete Urinalysis (panel test) – lowest priority test • Example of A2 result • Draft message completed - to be modified using “+” or “++ “for bilirubin result value • Example of A4 results • Urine sediment comments

  8. Needed from Pilots • Testers and feedback for current version of Validation Suite tool http://lri.sipilotdevelopment.org/lri-dstu/ • Volunteers for 1-on-1 Webex testing • Especially EHR systems • Validation Suite to be ready in June 2012

  9. Pilot I Project Updates • Allscripts • Atlas Development • CAP • Cerner • Halfpenny Technologies • KHIE • LabLynx • RML

  10. Value Proposition • Create value proposition statements for • Ambulatory Providers • Laboratories (does this vary by type) • Vendors • EHR • LIS • HIE • System Integrators • Value possibilities • Setup cost (each party) • Support cost (each party) • Reduced errors • Reduced TAT • Improved care delivery

  11. Next Steps / Questions • Next Steps • Continue recruiting Pilot II partipants • Work on expanded scenarios for validation suite • Schedule • Pilot calls for coordination every other week at same time 5/1, 5/15, 5/29, … • Continue work with Validation Suite on 5/22 • Start participation in LOI and compendium effort based on LOI calendar • For questions, please feel free to contact • Bob Dieterle: rdieterle@enablecare.us

More Related